Sociedad Americana de Hirudoterapia

Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy

Case report published in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2022)

Última actualización: March 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Seguridad y control de infeccionesEnsayos clínicosGenómica y proteómicaMcCracken J, Koehler S, Sharma R · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Abstract

PURPOSE: To describe challenges in the management of prophylaxis against infections for patients receiving medicinal leech therapy given changes in antimicrobial resistance patterns in the normal flora of leeches. SUMMARY: This article presents a patient case of reconstructive surgery complicated by infection associated with the use of medicinal leeches, as well as a discussion of prophylaxis in medicinal leech therapy, focusing on considerations for choosing a prophylactic agent. CONCLUSION: Our case report highlights resistance changes in Aeromonas isolates associated with medicinal leeches and the potential for complications if isolates resistant to chosen prophylactic agents arise. When administering antimicrobial prophylaxis in patients receiving medicinal leech therapy, clinicians should be familiar with the susceptibilities of Aeromonas species but also conscious of evolving antimicrobial resistance given the extent of the consequences of infected surgical grafts.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAnimalsAnti-Bacterial AgentsEthnicityHumansLeechesLeeching

Resumen

To describe challenges in the management of prophylaxis against infections for patients receiving medicinal leech therapy given changes in antimicrobial resistance patterns in the normal flora of leeches.

Por qué esto importa para la hirudoterapia

Informs safety protocols and infection prevention strategies for clinical leech therapy.

Citación

Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy.

McCracken J, Koehler S, Sharma R · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Contexto clínico relacionado

Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: March 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy | ASH